| Literature DB >> 34686551 |
Hamidah Hussain1,2, Amyn Malik2, Junaid F Ahmed3, Sara Siddiqui3, Farhana Amanullah4, Jacob Creswell5, Thorkild Tylleskär6, Bjarne Robberstad6,7.
Abstract
OBJECTIVES: Despite WHO guidelines recommending household contact investigation, and studies showing the impact of active screening, most tuberculosis (TB) programmes in resource-limited settings only carry out passive contact investigation. The cost of such strategies is often cited as barriers to their implementation. However, little data are available for the additional costs required to implement this strategy. We aimed to estimate the cost and cost-effectiveness of active contact investigation as compared with passive contact investigation in urban Pakistan.Entities:
Keywords: health economics; health policy; tuberculosis
Mesh:
Year: 2021 PMID: 34686551 PMCID: PMC8543626 DOI: 10.1136/bmjopen-2021-049658
Source DB: PubMed Journal: BMJ Open ISSN: 2044-6055 Impact factor: 3.006
Figure 1Household contacts evaluated and diagnosed for TB by passive, enhanced and active contact investigation interventions (CI). TB, tuberculosis.
Figure 2Decision tree for household contacts evaluated for TB by passive, enhanced and active contact investigation interventions (CI). TB, tuberculosis.
Modelling inputs, assumptions and ranges for passive, enhanced and active contact investigation (CI)
| Interventions | Total cost | Index patient with TB | Total contacts diagnosed with TB | Cost per index TB patient family screened | Probability of finding a patient with TB per household screened (lower and upper limit) |
| Passive CI | US$10 659 | 231 | 21 (17–25) | 46 (37-55) | 0.09 (0.07–0.10) |
| Passive +enhanced CI | US$19 597 | 300 | 102 (82–122) | 76 (61–91) | 0.34 (0.27–0.40) |
| Passive +enhanced + active CI | US$32 282 | 300 | 155 (124–186) | 118 (94–142) | 0.52 (0.41–0.62) |
TB, tuberculosis.
Cost (USD) of household contact screening for passive, enhanced and active contact investigation activities (upper panel), and cumulative costs per intervention arm (lower panel)
| Intervention activities | Passive contact investigation N=231 (%) | Enhanced contact investigation N=300 (%) | Active contact investigation N=300 (%) |
| Recurrent costs: | |||
| Clinic rental and maintenance | 3492 (33) | – | – |
| Personnel | 5354 (50) | 3835 (42) | 7348 (57) |
| Diagnostic tests | 1478 (14) | 2192 (24) | 2374 (18) |
| Supervision and monitoring | 116 (1) | 195 (2) | 39 (0) |
| Communication | 58 (1) | 204 (2) | 204 (2) |
| Training | 72 (1) | 72 (1) | 70 (1) |
| Stationary | 88 (1) | 22 (0) | 24 (0) |
| Subtotal recurrent costs | 10 659 | 6520 | 10 096 |
| Capital costs: | |||
| Equipment | – | 407 (4) | 407 (3) |
| Data collection system and maintenance | – | 2236 (24) | 2422 (19) |
| Subtotal capital costs | 2463 | 2829 | |
| Annuitised capital costs (3% discount rate) | 2419 | 2589 | |
| Total costs per activity | 10 659 | 8938 | 12 685 |
| Total costs per activity per index patient |
|
|
|
| Intervention arm | Passive | Passive +enhanced | Passive +enhanced + active |
| Total cumulated costs per index patient per arm for household contacts evaluated for TB |
|
|
|
| No of contacts diagnosed with TB |
|
|
|
Incremental cost-effectiveness of household contact screening for passive, enhanced and active contact investigation interventions from the TB programme perspective
| Strategy | Cost per strategy | Incremental cost | Effect | Incremental effect | ICER |
| Passive contact investigation | 46 | 0.09 | |||
| Passive +enhanced contact investigation | 76 | 30 | 0.34 | 0.25 | 120 |
| Passive +enhanced+active contact investigation | 118 | 42 | 0.52 | 0.18 | 238 |
ICER, incremental cost-effectiveness ratio; TB, tuberculosis.
Figure 3Cost-effectiveness (CE) acceptability curves for passive, enhanced and active contact investigation interventions (CI) for a range of willingness to pay per household screened.
Figure 4One-way sensitivity analyses for the ICERs of enhanced contact investigation compared with active contact investigation (CI). ICER, incremental cost-effectiveness ratio; TB, tuberculosis.